Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19)

…, H van der Hoeven, MH Reijers… - Clinical Infectious …, 2021 - academic.oup.com
Background Long-term health sequelae of coronavirus disease 2019 (COVID-19) may be
multiple but have thus far not been systematically studied. Methods All patients discharged …

Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients

…, LAB Joosten, MG Netea, MH Reijers… - Clinical & …, 2015 - Wiley Online Library
Background Allergic bronchopulmonary aspergillosis ( ABPA ) is characterised by an exaggerated
Th2 response to A spergillus fumigatus, but the immunological pathways responsible …

[HTML][HTML] Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis

…, Q de Mast, J Ten Oever, W Hoefsloot, MH Reijers… - PloS one, 2021 - journals.plos.org
Background To date, survival data on risk factors for COVID-19 mortality in western Europe
is limited, and none of the published survival studies have used a competing risk approach. …

[HTML][HTML] Aerosol transmission of Aspergillus fumigatus in cystic fibrosis patients in the Netherlands

…, WJG Melchers, MH Reijers… - Emerging infectious …, 2019 - ncbi.nlm.nih.gov
We collected sputum samples and cough plates from 15 cystic fibrosis patients in the
Netherlands who were colonized with Aspergillus fumigatus; we recovered A. fumigatus of the …

Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients

…, SEM Vonk, J Roukema, MH Reijers… - Pharmacology …, 2022 - Wiley Online Library
Elexacaftor/tezacaftor/ivacaftor (ETI) is a cystic fibrosis (CF) transmembrane conductance
regulator modulator, which has shown efficacy in CF patients (≥6 years) with ≥1 Phe508del …

[HTML][HTML] Evaluation of a new culture protocol for enhancing fungal detection rates in respiratory samples of cystic fibrosis patients

…, M Tehupeiory-Kooreman, WJG Melchers, MH Reijers… - Journal of Fungi, 2020 - mdpi.com
Cystic fibrosis (CF) can be complicated by fungal infection of the respiratory tract. Fungal
detection rates in CF sputa are highly dependent on the culture protocol and incubation …

[HTML][HTML] A multidisciplinary approach to fungal infections: one-year experiences of a center of expertise in mycology

NAF Janssen, RJM Brüggemann, MH Reijers… - Journal of Fungi, 2020 - mdpi.com
Invasive fungal diseases (IFDs) often represent complicated infections in complex patient
populations. The Center of Expertise in Mycology Radboudumc/CWZ (EMRC) organizes a …

Prevalence of nontuberculous mycobacteria in COPD patients with exacerbations

…, J van Ingen, C Magis-Escurra, MH Reijers… - Journal of …, 2013 - journalofinfection.com
In a recent paper published in this journal, Barberan et al. 1 explored the clinical relevance
of Aspergillus isolation from respiratory specimens of COPD patients. Forty percent of the …

Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis

…, C Magis-Escurra, MH Reijers… - European …, 2016 - Eur Respiratory Soc
The respiratory tract of patients with cystic fibrosis (CF) is colonised with a high diversity of
micro-organisms. Nontuberculous mycobacteria (NTM) show a high and increasing …

[HTML][HTML] Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant Aspergillus flavus Isolates

JB Buil, J Houbraken, MH Reijers, J Zoll, M Sanguinetti… - Journal of Fungi, 2021 - mdpi.com
Aspergillus flavus is a pathogenic fungal species that can cause pulmonary aspergillosis,
and triazole compounds are used for the treatment of these infections. Prolonged exposure to …